Clinical Trials · NCT00495846
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Federico II University
- Enrollment
- 25
- Start date
- Apr 2007
- Locations
- 1 site, Italy
- Primary endpoint
- Prolongation of the survival curve (>6 months)